The study is geared toward patients with atrial fibrillation, or AFib ... while others will use the "pill-in-pocket" treatment in which the pills are taken as needed using a study app on an ...

This portable, self-administered treatment may provide patients with ... and Phase 2 trial for the treatment of patients with AFib-RVR. Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a ...

This portable, self-administered treatment may provide patients with ... and Phase 2 trial for the treatment of patients with AFib-RVR. Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a ...